Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Infectious Diseases

• Publication date

  1999-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/514316PMID 9988190
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever.

  1998cited by this paper
• A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever.

  1998cited by this paper
• Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses.

  1996cited by this paper
• Pharmacokinetics of the antiviral agent 3-deazaneplanocin A

  1995cited by this paper
• Differentiation of filoviruses by electron microscopy.

  1995cited by this paper
• Pharmacokinetics of the antiviral agent carbocyclic 3-deazaadenosine.

  1993cited by this paper
• Antibodies to Puumala virus in humans determined by neutralization test.

  1992cited by this paper
• Antiviral (RNA) activity of selected Amaryllidaceae isoquinoline constituents and synthesis of related substances.

  1992cited by this paper
• Inhibition of ebola virus replication in vitro and in a SCID mouse model by S-adenosylhomocysteine hydrolase inhibitors

  1991cited by this paper
• Evaluation of the toxicity and antiviral activity of carbocyclic 3-deazaadenosine against respiratory syncytial and parainfluenza type 3 viruses in tissue culture and in cotton rats.

  1990cited by this paper
• RNA Viruses that Cause Hemorrhagic, Encephalitic, and Febrile Disease

  1990cited by this paper
• Antiviral Agents and Viral Diseases of Man

  1990cited by this paper
• The nucleoprotein gene of Ebola virus: cloning, sequencing, and in vitro expression.

  1989cited by this paper
• Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug.

  1989cited by this paper
• S-adenosylhomocysteine hydrolase inhibitors as broad-spectrum antiviral agents.

  1987cited by this paper
• Broad-spectrum antiviral activity of the carbocyclic analog of 3-deazaadenosine.

  1983cited by this paper
• Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent

  1983cited by this paper
• Carbocyclic analogue of 3-deazaadenosine: a novel antiviral agent using S-adenosylhomocysteine hydrolase as a pharmacological target.

  1982cited by this paper
• Plaque Assay for Ebola Virus

  1981cited by this paper
• Adenosine analogues as substrates and inhibitors of S-adenosylhomocysteine hydrolase.

  1981cited by this paper
• Ebola virus haemorrhagic fever

  1978cited by this paper
• A case of Ebola virus infection.

  1977cited by this paper

• Efficacy evaluation of the S-adenosylhomocysteine hydrolase inhibitor MSD-914 in rhesus macaques (Macaca Mulatta) challenged with Ebola virus by the intramuscular route

  2026cites this paper
• AHCY: A Metabolic Gatekeeper at the Interface of Methylation, Redox Balance, and Cellular Stress Response.

  2026cites this paper
• Nucleoside antiviral agents with atypical structures and new targets.

  2025cites this paper
• Ginkgolic acid Inhibits Ebola Virus Transcription and Replication by Disrupting the Interaction Between Nucleoprotein and VP30 Protein.

  2024cites this paper
• N6-methyladenosine is required for efficient RNA synthesis of Ebola virus and other haemorrhagic fever viruses

  2023cites this paper
• History and impact of the mouse-adapted Ebola virus model.

  2022cites this paper
• The use of an Ebola virus reporter cell line in a semi-automated microtitration assay.

  2021cites this paper
• 6′,6′-Difluoro-aristeromycin is a potent inhibitor of MERS-coronavirus replication

  2021cites this paper
• Mechanisms of anti-vesicular stomatitis virus activity of deazaneplanocin and its 3-brominated analogues.

  2021cites this paper
• Functional and Pathological Roles of AHCY

  2021cites this paper
• The discovery and development of novel treatment strategies for filoviruses

  2021cites this paper
• Anno 2021: Which antivirals for the coming decade?

  2021cites this paper
• A narrative review of herbal preparations against RNA viruses

  2021cites this paper
• Antivirals in medical biodefense

  2020cites this paper
• Social, Cognitive, and Emotional Predictors of Adherence to Physical Distancing During the COVID-19 Pandemic

  2020cites this paper
• Discovery and Structural Optimization of 4-(Aminomethyl)benzamides as Potent Entry Inhibitors of Ebola and Marburg Virus Infections.

  2020cites this paper
• Virus and host interactions critical for filoviral RNA synthesis as therapeutic targets

  2019cites this paper
• Developing Therapeutics for Ebola Virus Disease: A Multifaceted Approach

  2019cites this paper
• Current status of small molecule drug development for Ebola virus and other filoviruses.

  2019cites this paper
• Translating Models of Support for Women with Chronic Viral Infection to Address the Reproductive Health Needs of West African Ebola Survivors

  2019cites this paper
• Computational Drug Design against Ebola Virus Targeting Viral Matrix Protein VP30

  2019cites this paper
• Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus

  2018cites this paper
• 6'-Fluoro-3-deazaneplanocin: Synthesis and antiviral properties, including Ebola.

  2018cites this paper
• Ebola Virus Disease: Progress So Far in the Management of the Disease

  2018cites this paper
• A REVIEW ON EBOLA VIRUS, THE DISEASES, CAUSES AND MANAGEMENT

  2017cites this paper
• Assessment of Inhibition of Ebola Virus Progeny Production by Antiviral Compounds.

  2017cites this paper
• Filovirus proteins for antiviral drug discovery: Structure/function bases of the replication cycle

  2017cites this paper
• Molecular Docking, Pharmacophore, and 3D-QSAR Approach: Can Adenine Derivatives Exhibit Significant Inhibitor Towards Ebola Virus?

  2017cites this paper
• Applications of Biotechnology for Sustainable Development

  2017cites this paper
• Viral Epitranscriptomics

  2017cites this paper
• Modelling of l -protein from Ebola Virus and Development of Its New Inhibitor Molecules: An In Silico Approach

  2017cites this paper
• [Ebola virus disease: Clinical presentation, prognosis and treatment].

  2017cites this paper
• How treat viral infections in ICU patients.

  2016cites this paper
• Secondary metabolites extracted from marine sponge associated Comamonas testosteroni and Citrobacter freundii as potential antimicrobials against MDR pathogens and hypothetical leads for VP40 matrix protein of Ebola virus: an in vitro and in silico investigation

  2016cites this paper
• Strategies for the Development of Small Molecule Inhibitors of Ebola Viral Infection

  2016cites this paper
• Therapeutic Strategies against Ebola Virus Infection

  2016influential citation
• Viruses Causing Hemorrhagic Fever. Safety Laboratory Procedures

  2016cites this paper
• Ebola virus: current and future perspectives.

  2015cites this paper
• Viral haemorrhagic fevers

  2015cites this paper
• Development of Small‐Molecule Antivirals for Ebola

  2015cites this paper
• BOISE STATE UNIVERSITY GRADUATE COLLEGE DEFENSE COMMITTEE AND FINAL READING APPROVALS

  2015cites this paper
• Ebola virus outbreak, updates on current therapeutic strategies

  2015cites this paper
• Determination and Therapeutic Exploitation of Ebola Virus Spontaneous Mutation Frequency

  2015cites this paper
• Small molecule inhibitors of ebola virus infection.

  2015cites this paper
• Promising Therapeutics against Ebola Virus Disease.

  2015cites this paper
• Ebola virus – current threats and perspectives for control of infections

  2015cites this paper
• Ebola virus disease: past, present and future

  2015cites this paper
• A review on the Ebola virus, outbreak history and the current research tools to control the disease

  2015cites this paper
• Elucidation of the Ebola virus VP24 cellular interactome and disruption of virus biology through targeted inhibition of host-cell protein function.

  2014cites this paper
• New rules needed to stop the Ebola epidemic.

  2014cites this paper
• Marburg and Ebola Hemorrhagic Fevers (Filoviruses)

  2014cites this paper
• How to approach and treat viral infections in ICU patients

  2014cites this paper
• Imino sugar glucosidase inhibitors as broadly active anti-filovirus agents

  2013cites this paper
• Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses.

  2013cites this paper
• S-adenosyl-L-homocysteine hydrolase and methylation disorders: Yeast as a model system

  2013cites this paper
• Etude de la modulation de la réponse cellulaire au stress oxydatif par les protéines VP24 des virus Marburg et Ebola

  2012cites this paper
• Biodefense Research Methodology and Animal Models, Second Edition

  2012cites this paper
• Mouse Models for Filovirus Infections

  2012cites this paper
• 2′-Fluoro-3-deazaaristeromycin

  2012cites this paper
• Discovery, synthesis, and biological evaluation of a novel group of selective inhibitors of filoviral entry.

  2011cites this paper
• Developments in antivirals against influenza, smallpox and hemorrhagic fever viruses

  2011cites this paper
• Strategies in the design of antiviral drugs

  2010cites this paper
• Viral zoonosis: a comprehensive review.

  2010cites this paper
• Hemorrhagic Fever Viruses as Biological Weapons

  2009cites this paper
• “Filoviruses”: a real pandemic threat?

  2009cites this paper
• Looking back in 2009 at the dawning of antiviral therapy now 50 years ago an historical perspective.

  2009cites this paper
• The Viral Hemorrhagic Fevers

  2009cites this paper
• Molecular strategies to inhibit the replication of RNA viruses

  2008cites this paper
• The discovery of antiviral agents: Ten different compounds, ten different stories

  2008cites this paper
• Animal models of highly pathogenic RNA viral infections: hemorrhagic fever viruses.

  2008cites this paper
• Filoviruses - Ebola and Marburg

  2008cites this paper
• Filoviruses attach to a common cell-surface molecule via distinct and strongly immunogenic receptor-binding regions, and modulate cell entry through Δ-peptides

  2008cites this paper
• Chromatin, cancer and drug therapies.

  2008cites this paper
• Structure and function of S-adenosylhomocysteine hydrolase

  2007cites this paper
• Goraczka krwotoczna Ebola. Immunologiczne i molekularne mechanizmy patogenezy, diagnostyka, eksperymentalne metody leczenia i uodparniania

  2007cites this paper
• Analyse phylogénétique des souches du virus de la fièvre hémorragique Ebola et mise en évidence de souches atypiques

  2007cites this paper
• Therapy of Ebola and Marburg virus infections

  2006cites this paper
• Viral hemorrhagic fevers.

  2006cites this paper
• Progress towards the treatment of Ebola haemorrhagic fever

  2006cites this paper
• Postexposure Protection of Guinea Pigs against a Lethal Ebola Virus Challenge Is Conferred by RNA Interference

  2006cites this paper
• Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening.

  2005cites this paper
• Antiviral Drug Discovery for Emerging Diseases and Bioterrorism Threats: Torrence/Antiviral Drug Discovery for Emerging Diseases and Bioterrorism Threats

  2005cites this paper
• "Molecular chameleons". Design and synthesis of a second series of flexible nucleosides.

  2005cites this paper
• Review A survey of antiviral drugs for bioweapons

  2005cites this paper
• Antimicrobials for Biological Warfare Agents

  2005cites this paper
• A Survey of Antiviral Drugs for Bioweapons

  2005cites this paper
• Exotic emerging viral diseases: progress and challenges

  2004cites this paper
• S‐Adenosyl methionine/S‐adenosyl‐L‐homocysteine ratio determination by capillary electrophoresis employed as a monitoring tool for the antiviral effectiveness of adenosine analogs

  2004cites this paper
• Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions

  2004cites this paper
• Responding to Epidemics of Ebola Hemorrhagic Fever: Progress and Lessons Learned from Recent Outbreaks in Uganda, Gabon, and Congo

  2004cites this paper
• Emerging viral infections

  2004cites this paper
• Other viral bioweapons: Ebola and Marburg hemorrhagic fever.

  2004cites this paper
• Treating viral hemorrhagic fever.

  2003cites this paper
• Prospects for antiviral therapy.

  2003cites this paper
• Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.

  2003cites this paper
• Preventive and therapeutic approaches to viral agents of bioterrorism.

  2003cites this paper
• Defense against filoviruses used as biological weapons.

  2003cites this paper
• Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections

  2003cites this paper
• Strategies in the design of antiviral drugs

  2002cites this paper
• Other Viruses and Emerging Viruses of Concern

  2002cites this paper